These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9801804)

  • 1. Chromium levels in patients with internal diseases.
    Zima T; Mestek O; Tesar V; Tesarová P; Nĕmecek K; Zák A; Zeman M
    Biochem Mol Biol Int; 1998 Oct; 46(2):365-74. PubMed ID: 9801804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between Glycemic Status and Serum Chromium Level with Type 2 Diabetes Mellitus.
    Eva H; Akter QS; Alam MK
    Mymensingh Med J; 2020 Jan; 29(1):183-186. PubMed ID: 31915356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus.
    Ekin S; Mert N; Gunduz H; Meral I
    Biol Trace Elem Res; 2003 Sep; 94(3):193-201. PubMed ID: 12972687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats.
    Lai MH; Chen YY; Cheng HH
    Int J Vitam Nutr Res; 2006 Nov; 76(6):391-7. PubMed ID: 17607959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in selected serum parameters of broiler chicken fed supplemental chromium.
    Króliczewska B; Zawadzki W; Dobrzanski Z; Kaczmarek-Oliwa A
    J Anim Physiol Anim Nutr (Berl); 2004 Dec; 88(11-12):393-400. PubMed ID: 15584948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes.
    Sadri H; Larki NN; Kolahian S
    Biol Trace Elem Res; 2017 Dec; 180(2):246-254. PubMed ID: 28409409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromium status of tannery workers in relation to metabolic disorders.
    Stupar J; Vrtovec M; Kocijancic A; Gantar A
    J Appl Toxicol; 1999; 19(6):437-46. PubMed ID: 10547626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels.
    Uusitupa MI; Mykkänen L; Siitonen O; Laakso M; Sarlund H; Kolehmainen P; Räsänen T; Kumpulainen J; Pyörälä K
    Br J Nutr; 1992 Jul; 68(1):209-16. PubMed ID: 1390605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high-chromium brewer's yeast on human serum lipids.
    Elwood JC; Nash DT; Streeten DH
    J Am Coll Nutr; 1982; 1(3):263-74. PubMed ID: 7185858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study.
    Ngala RA; Awe MA; Nsiah P
    PLoS One; 2018; 13(7):e0197977. PubMed ID: 29975702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes.
    Abraham AS; Brooks BA; Eylath U
    Metabolism; 1992 Jul; 41(7):768-71. PubMed ID: 1619996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-automated determination of chromium in whole blood and serum by Zeeman electrothermal atomic absorption spectrophotometry.
    Schermaier AJ; O'Connor LH; Pearson KH
    Clin Chim Acta; 1985 Oct; 152(1-2):123-34. PubMed ID: 4053394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive lipid-lowering strategy in patients with diabetes mellitus.
    Kanters SD; Algra A; de Bruint TW; Erkelens DW; Banga JD
    Diabet Med; 1999 Jun; 16(6):500-8. PubMed ID: 10391399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of chromium in whole blood and erythrocytes showed different relationships with serum apolipoprotein levels in Cr(VI) exposed subjects.
    Feng H; Ha F; Hu G; Wu Y; Yu S; Ji Z; Feng W; Wang T; Jia G
    J Trace Elem Med Biol; 2018 Dec; 50():384-392. PubMed ID: 30262309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of hormonal replacement therapy on chromium status and glucose and lipid metabolism in postmenopausal women.
    Roussel AM; Bureau I; Favier M; Polansky MM; Bryden NA; Anderson RA
    Maturitas; 2002 May; 42(1):63-9. PubMed ID: 12020981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum chromium of human subjects: effects of chromium supplementation and glucose.
    Anderson RA; Bryden NA; Polansky MM
    Am J Clin Nutr; 1985 Mar; 41(3):571-7. PubMed ID: 3976556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus.
    Stupar J; Vrtovec M; Dolinsek F
    Metabolism; 2007 Jan; 56(1):94-104. PubMed ID: 17161231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.